Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amitabh B Suthar

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Public Health Action|September 23, 2015
What's next for tuberculosis control in sub-Saharan Africa?Amitabh B Suthar
Plos Medicine|December 13, 2017
Antiretroviral therapy and population mortality: Leveraging routine national data to advance policyAmitabh B Suthar, Till Bärnighausen
The Journal of Infectious Diseases|March 30, 2016
Reply to Davey et alAmitabh B Suthar, Brian G Williams
Plos Medicine|March 11, 2015
A public health approach to hepatitis C control in low- and middle-income countriesAmitabh B Suthar, Anthony D Harries
The Journal of Infectious Diseases|October 12, 2018
Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDSAmitabh B Suthar, William Coggin, Elliot Raizes
The Lancet. HIV|October 2, 2015
Co-trimoxazole in people on antiretroviral therapy for HIV--authors' replyAmitabh B Suthar, Marco A Vitoria, Meg C Doherty
Plos Medicine|September 15, 2018
Towards national systems for continuous surveillance of antimicrobial resistance: Lessons from tuberculosisAmitabh B Suthar, Patrick K Moonan, Heather L Alexander
Bulletin of the World Health Organization|March 17, 2012
Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysisAmitabh B Suthar, Reuben Granich, Jonathan Mermin, et al.
The Lancet. Infectious Diseases|December 21, 2013
Towards national and global measurement of antiretroviral therapy effectivenessAmitabh B Suthar, Jesus M Garcia Calleja, Gundo A Weiler
The Lancet. Infectious Diseases|October 31, 2015
Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulationAnthony D Harries, Stephen D Lawn, Amitabh B Suthar, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Public Health Action|September 23, 2015
What's next for tuberculosis control in sub-Saharan Africa?Amitabh B Suthar
Plos Medicine|December 13, 2017
Antiretroviral therapy and population mortality: Leveraging routine national data to advance policyAmitabh B Suthar, Till Bärnighausen
The Journal of Infectious Diseases|March 30, 2016
Reply to Davey et alAmitabh B Suthar, Brian G Williams
Plos Medicine|March 11, 2015
A public health approach to hepatitis C control in low- and middle-income countriesAmitabh B Suthar, Anthony D Harries
The Journal of Infectious Diseases|October 12, 2018
Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDSAmitabh B Suthar, William Coggin, Elliot Raizes
The Lancet. HIV|October 2, 2015
Co-trimoxazole in people on antiretroviral therapy for HIV--authors' replyAmitabh B Suthar, Marco A Vitoria, Meg C Doherty
Plos Medicine|September 15, 2018
Towards national systems for continuous surveillance of antimicrobial resistance: Lessons from tuberculosisAmitabh B Suthar, Patrick K Moonan, Heather L Alexander
Bulletin of the World Health Organization|March 17, 2012
Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysisAmitabh B Suthar, Reuben Granich, Jonathan Mermin, et al.
The Lancet. Infectious Diseases|December 21, 2013
Towards national and global measurement of antiretroviral therapy effectivenessAmitabh B Suthar, Jesus M Garcia Calleja, Gundo A Weiler
The Lancet. Infectious Diseases|October 31, 2015
Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulationAnthony D Harries, Stephen D Lawn, Amitabh B Suthar, et al.
Pageof 4